SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
Sinovac Amends Shareholder Rights Plan
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the Company’s subsidiary, Sinovac Biotech Co., Ltd. (“Sinovac Beijing”), has changed its legal representative to Mr. Weidong Yin, the Company’s Chairman, President and Chief Executive Officer.
SINOVAC Reports Unaudited First Half of 2023 Financial Results
Amplia Therapeutics has reported data demonstrating the efficacy of AMP945 in a preclinical model of pancreatic cancer when used along with FOLFIRINOX treatment.
Sinovac Amends Shareholder Rights Plan
China has opened up its doors to a foreign Covid-19 vaccine for the first time, though not for its own citizens, a German government spokesperson told Reuters on Wednesday.
BERLIN, Dec 7 (Reuters) - German health minister Karl Lauterbach has granted a permit allowing China's Sinovac (SVA.O) COVID-19 vaccine to be imported to Germany from Wednesday, but it will only be given to Chinese citizens in that country, the Spiegel magazine reported.